138 related articles for article (PubMed ID: 23006538)
1. A nanostructured liquid crystalline formulation of 20(S)-protopanaxadiol with improved oral absorption.
Jin X; Zhang ZH; Li SL; Sun E; Tan XB; Song J; Jia XB
Fitoterapia; 2013 Jan; 84():64-71. PubMed ID: 23006538
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.
Jin X; Zhang ZH; Sun E; Tan XB; Li SL; Cheng XD; You M; Jia XB
Int J Nanomedicine; 2013; 8():641-52. PubMed ID: 23426652
[TBL] [Abstract][Full Text] [Related]
3. A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo.
Xia HJ; Zhang ZH; Jin X; Hu Q; Chen XY; Jia XB
Int J Nanomedicine; 2013; 8():545-54. PubMed ID: 23431115
[TBL] [Abstract][Full Text] [Related]
4. [Polybasic research on the biopharmaceutical characteristics of 20 (S)-protopanaxadiol].
Jin X; Zhang ZH; Sun E; Tan XB; Xia HJ; Liu QY; Jia XB
Yao Xue Xue Bao; 2013 Mar; 48(3):411-6. PubMed ID: 23724657
[TBL] [Abstract][Full Text] [Related]
5. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.
Ren HC; Sun JG; Wang GJ; A JY; Xie HT; Zha WB; Yan B; Sun FZ; Hao HP; Gu SH; Sheng LS; Shao F; Shi J; Zhou F
J Pharm Biomed Anal; 2008 Dec; 48(5):1476-80. PubMed ID: 19022601
[TBL] [Abstract][Full Text] [Related]
6. Self-microemulsifying Drug Delivery System Improved Oral Bioavailability of 20(S)-Protopanaxadiol: From Preparation to Evaluation.
Wang B; Pu Y; Xu B; Tao J; Wang Y; Zhang T; Wu P
Chem Pharm Bull (Tokyo); 2015; 63(9):688-93. PubMed ID: 26084568
[TBL] [Abstract][Full Text] [Related]
7. [Study on pharmacokinetics of 20 (S) -protopanaxadiol lipid cubic nanoparticles].
Jin X; Zhang ZH; Sun E; Liu QY; Jia XB
Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):263-8. PubMed ID: 23672053
[TBL] [Abstract][Full Text] [Related]
8. Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery.
Chen C; Wang L; Cao F; Miao X; Chen T; Chang Q; Zheng Y
Int J Pharm; 2016 Jan; 497(1-2):239-47. PubMed ID: 26680316
[TBL] [Abstract][Full Text] [Related]
9. Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats.
Kong LT; Wang Q; Xiao BX; Liao YH; He XX; Ye LH; Liu XM; Chang Q
Fitoterapia; 2013 Apr; 86():48-53. PubMed ID: 23391424
[TBL] [Abstract][Full Text] [Related]
10. Formulation and Characterization of Novel Dry Suspension and Dry Emulsion of 20(S)-Protopanaxadiol.
Zhang L; Xu C; Mao J; Wang W; Han H; Pu Y; Zhang T
AAPS PharmSciTech; 2019 Aug; 20(7):275. PubMed ID: 31388863
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.
Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B
Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104
[TBL] [Abstract][Full Text] [Related]
13. Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models.
Sun H; Bi H; Huang M; Liu D; Qin Z
Biopharm Drug Dispos; 2010 Nov; 31(8-9):486-94. PubMed ID: 20936649
[TBL] [Abstract][Full Text] [Related]
14. A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy.
Han M; Ma L; Yu X; Li Z; Guo Y; Wang X
Drug Deliv; 2016 Sep; 23(7):2410-2418. PubMed ID: 25564965
[TBL] [Abstract][Full Text] [Related]
15. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
Avachat AM; Parpani SS
Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
[TBL] [Abstract][Full Text] [Related]
16. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
[TBL] [Abstract][Full Text] [Related]
17. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
18. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability.
Tan QY; Hu NN; Liu GD; Yin HF; Zhang L; Wang H; Lu LY; Zhang JQ
Arch Pharm Res; 2012 Mar; 35(3):499-508. PubMed ID: 22477197
[TBL] [Abstract][Full Text] [Related]
19. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.
Lai J; Chen J; Lu Y; Sun J; Hu F; Yin Z; Wu W
AAPS PharmSciTech; 2009; 10(3):960-6. PubMed ID: 19636709
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
